A Randomized Controlled Trial of Combined Ivermectin and Zinc Sulfate versus Combined Hydroxychloroquine, Darunavir/Ritonavir, and Zinc Sulfate among Adult Patients with Asymptomatic or Mild Coronavirus-19 Infection

INTRODUCTION: Ivermectin, hydroxychloroquine (HQ), and darunavir/ritonavir are widely prescribed as an oral treatment for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection despite their uncertainty of clinical benefit. The objective is to determine the safety and the efficacies...

Descripción completa

Detalles Bibliográficos
Autores principales: Nimitvilai, Sireethorn, Suputtamongkol, Yupin, Poolvivatchaikarn, Ussanee, Rassamekulthana, Dechatorn, Rongkiettechakorn, Nuttawut, Mungaomklang, Anek, Assanasaen, Susan, Wongsawat, Ekkarat, Boonarkart, Chompunuch, Sawaengdee, Waritta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336605/
https://www.ncbi.nlm.nih.gov/pubmed/35910820
http://dx.doi.org/10.4103/jgid.jgid_281_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9336605/
https://www.ncbi.nlm.nih.gov/pubmed/35910820
http://dx.doi.org/10.4103/jgid.jgid_281_21

Ejemplares similares